Back to Directory

Goserelin

Performance & Endurance

GnRH agonist depot for prostate and breast cancer, endometriosis, monthly or 3-monthly.

Key Benefits

  • ✓Hormone suppression for cancers
  • ✓Treats endometriosis
  • ✓Monthly or 3-monthly depot
  • ✓Multiple indications
  • ✓Long-acting

Dosing Information

Dosage Range
3.6-10.8 mg
Frequency
Monthly or every 3 months
Typical Duration
Based on indication

Detailed Protocol

Administered as subcutaneous depot implant in abdomen. Biocompatible cylinder inserted under skin. 1-month (3.6mg) or 3-month (10.8mg) formulations. Medical office procedure.

About Goserelin

Goserelin (Zoladex) is a synthetic decapeptide GnRH agonist administered as a depot implant. Available in 1-month and 3-month formulations. FDA-approved for prostate cancer, breast cancer, endometriosis, and endometrial thinning before procedures.

Research Notes

FDA-approved for multiple hormone-dependent conditions. Widely used since 1989. Convenient depot formulation. Multiple indications from cancer to endometriosis.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Hot flashes
  • •Sexual dysfunction
  • •Initial flare with first dose
  • •Bone density loss
  • •Mood changes
  • •Tumor flare possible

Always consult with a healthcare professional before starting any peptide therapy.